跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“KCC2”
全部
20
临床试验
8
药物
4
机构
0
资讯
8
9个月前
Ovid Therapeutics Reports First-in-Human Safety Data for Novel KCC2 Direct Activator OV350
去年
Drug Hunter Highlights Key Pharmaceutical Patents and Clinical Updates from Late 2024
10个月前
Ovid Therapeutics Advances OV329 to Phase 2 Following Positive Safety Results in Drug-Resistant Epilepsy Program
去年
Ovid Therapeutics Advances Novel Neurological Drug Pipeline with Key Clinical Milestones Expected in 2025-2026
11个月前
Ovid Therapeutics' OV329 Shows 53% GABA Inhibition in Phase 1 Trial for Drug-Resistant Epilepsy
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
2个月前
Ovid Therapeutics Reshapes Executive Leadership to Drive Next Phase of CNS Pipeline Development
去年
Ovid Therapeutics Sells Ganaxolone Royalty Rights to Immedica Pharma for $7 Million